查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1560959

2024-2032 年按产品、技术、应用（肿瘤学、中枢神经系统、免疫学、呼吸医学、感染等）、最终用户和地区分類的精准医学市场报告

Precision Medicine Market Report by Product, Technology, Application (Oncology, Central Nervous System, Immunology, Respiratory Medicine, Infections, and Others), End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

2023年全球精准医疗IMARC Group规模达752亿美元。基因组学的重大进步、医疗保健个人化的提高、慢性病盛行率的上升、技术创新、研究投资的增加以及向更有效、客製化治疗的转变正在影响精准医疗产业。

精准医疗市场分析：

  • 市场成长与规模：在对个人化治疗方式的需求不断增长和基因组科学进步的推动下，精准医疗市场份额正在快速增长。精准医疗市场趋势反映在精准医疗应用范围的扩大和流入该领域的大量投资。
  • 主要市场驱动因素：主要驱动因素包括基因组学技术进步、慢性病盛行率上升、向个人化医疗保健的转变以及对研发 (R&D) 的大量投资。这些因素共同推动市场向前发展，与人们日益重视更有效和客製化的医疗保健解决方案一致。
  • 技术进步：基因定序、巨量资料分析和生物资讯学的创新至关重要，可以对遗传资料进行详细分析，从而促进个人化治疗策略。这种技术进步对于标靶治疗和精准诊断工具的开发至关重要。
  • 产业应用：精准医学在肿瘤学、中枢神经系统(CNS) 疾病、免疫学和呼吸医学等领域有着广泛的应用，它可以实现量身定制的治疗策略，从而改善患者的治疗效果和更有效的疾病管理。
  • 主要市场趋势：一些关键的精准医疗市场趋势包括人工智慧 (AI) 和机器学习 (ML) 的集成，以增强遗传资料的预测能力并改善患者护理的个人化。市场上伴随诊断也有所增加，强调了根据个人遗传资讯调整治疗决策的重要性。
  • 地理趋势：在先进的医疗保健基础设施和大量医疗保健投资的支持下，北美引领市场。然而，由于医疗保健意识的提高、医疗保健基础设施的投资以及政府对个人化医疗的支持，亚太地区正在快速成长。
  • 竞争格局：市场竞争激烈，主要参与者专注于创新、策略合作伙伴关係，并扩大其产品组合以包括复杂的精准医疗解决方案。竞争优势很大程度取决于技术创新、监管审批和市场扩张策略。
  • 挑战与机会：挑战包括高成本、复杂的监管环境以及广泛的资料整合需求。另一方面，这些挑战为降低成本、优化监管策略和开发先进资料分析以提高精准医疗的有效性和可及性提供了创新机会。

精准医疗市场趋势：

基因组学和生物资讯学的技术进步：

推动精准医疗市场成长的最重要驱动因素之一是基因组学和生物资讯学的快速发展。高通量定序技术使基因组定序变得更快、更便宜，使基因组资讯在临床实践中广泛使用。这导致了基于个体基因组成的个人化治疗的发展。此外，生物资讯学将生物资料与统计分析和计算工具相结合，在解释基因组测序产生的大量资料方面发挥着至关重要的作用。这些技术进步为识别导致各种疾病的基因突变以及开发改善治疗结果的标靶疗法铺平了道路，从而提高了精准医疗的市场份额。

慢性病盛行率增加：

癌症、糖尿病和心血管疾病（CVD）等慢性疾病的全球增加是有助于市场扩张的关键精准医疗市场趋势之一。这些疾病是全世界死亡和残疾的主要原因，给医疗保健系统带来了沉重负担。精准医学为管理这些疾病提供了一种有前途的方法，根据每位患者独特的基因谱，设计出针对性的治疗方法来治疗他们的疾病。这种个人化方法不仅提高了治疗效果，还降低了药物不良反应的风险，从而提高了患者的治疗效果并降低了医疗成本。随着这些疾病的盛行率持续上升，对精准医疗方法的需求预计将增长，从而推动精准医疗市场的成长。

不断增加的研发投入：

精准医疗产业的研发（R＆D）投资是另一个重要的成长诱导因素。政府、私人实体和慈善组织越来越多地资助精准医学的研发活动，以发现新的治疗标靶并开发新的诊断工具和治疗方法。这项投资对于生物标记的不断发现、伴随诊断的发展以及个人化治疗的进步至关重要。此类财政支援正在推动创新，并加速将科学发现转化为临床应用，从而促进精准医疗份额的成长。

转向个人化医疗保健：

由于对客製化治疗方案的需求不断增长以及对预防医学的日益重视，人们日益向个人化医疗保健转变，这正在推动精准医疗市场的成长。患者和医疗保健提供者越来越意识到个人化医疗的好处，例如提高治疗效果、最大限度地减少药物选择的试验和错误，以及从长远来看降低治疗成本。这一转变得到了电子健康记录 (EHR) 与基因组资料整合的支持，这增强了根据个人特征量身定制医疗的能力。因此，对精准医疗解决方案的需求不断增长，预计将提高精准医疗市场份额。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球精准医疗市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 耗材
    • 市场趋势
    • 市场预测
  • 仪器仪表
    • 市场趋势
    • 市场预测
  • 服务
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依技术

  • 大数据分析
    • 市场趋势
    • 市场预测
  • 生物资讯学
    • 市场趋势
    • 市场预测
  • 基因定序
    • 市场趋势
    • 市场预测
  • 药物发现
    • 市场趋势
    • 市场预测
  • 伴随诊断
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按应用

  • 肿瘤学
    • 市场趋势
    • 市场预测
  • 中枢神经系统 (CNS)
    • 市场趋势
    • 市场预测
  • 免疫学
    • 市场趋势
    • 市场预测
  • 呼吸内科
    • 市场趋势
    • 市场预测
  • 感染
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院和诊所
    • 市场趋势
    • 市场预测
  • 诊断中心
    • 市场趋势
    • 市场预测
  • 製药和生物技术公司
    • 市场趋势
    • 市场预测
  • 医疗保健 IT 公司
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AstraZeneca plc
    • Bayer AG
    • bioMerieux SA
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Qiagen NV
    • Quest Diagnostics Incorporated
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A4567

The global precision medicine market size reached US$ 75.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 168.3 Billion by 2032, exhibiting a growth rate (CAGR) of 9.1% during 2024-2032. Significant advancements in genomics, increasing healthcare personalization, rising prevalence of chronic diseases, technological innovations, growing investment in research, and a shift towards more effective, tailored treatments are influencing the precision medicine industry.

Precision Medicine Market Analysis:

  • Market Growth and Size: The precision medicine market share is experiencing rapid growth, driven by increasing demand for personalized treatment modalities and advancements in genomic science. Precision medicine market trends are reflected in the expanding range of precision medicine applications and the significant investments flowing into the sector.
  • Major Market Drivers: Key drivers include technological advancements in genomics, the rising prevalence of chronic diseases, a shift towards personalized healthcare, and substantial investments in research and development (R&D). These factors are collectively propelling the market forward, aligning with the growing emphasis on more effective and tailored healthcare solutions.
  • Technological Advancements: Innovations in gene sequencing, big data analytics, and bioinformatics are pivotal, enabling the detailed analysis of genetic data, which in turn facilitates personalized treatment strategies. Such technological progress is vital for the development of targeted therapies and precision diagnostic tools.
  • Industry Applications: Precision medicine finds extensive applications across oncology, central nervous system (CNS) disorders, immunology, and respiratory medicine, among others, where it enables tailored therapeutic strategies, leading to improved patient outcomes and more efficient disease management.
  • Key Market Trends: Some of the key precision medicine market trends include the integration of artificial intelligence (AI) and machine learning (ML) to enhance the predictive power of genetic data and improve the personalization of patient care. The market is also seeing a rise in companion diagnostics, emphasizing the importance of aligning therapeutic decisions with individual genetic information.
  • Geographical Trends: North America leads the market, supported by advanced healthcare infrastructure and significant healthcare investments. However, Asia Pacific is rapidly growing due to increasing healthcare awareness, investment in healthcare infrastructure, and governmental support for personalized medicine.
  • Competitive Landscape: The market is highly competitive, with key players focusing on innovation, strategic partnerships, and expanding their product portfolios to include sophisticated precision medicine solutions. The competitive edge is largely defined by technological innovation, regulatory approvals, and market expansion strategies.
  • Challenges and Opportunities: Challenges include high costs, complex regulatory environments, and the need for extensive data integration. On the other hand, these challenges present opportunities for innovation in cost reduction, regulatory strategy optimization, and the development of advanced data analytics to enhance the efficacy and accessibility of precision medicine.

Precision Medicine Market Trends:

Technological advancements in genomics and bioinformatics:

One of the most significant drivers driving the precision medicine market growth is the rapid advancement in genomics and bioinformatics. High-throughput sequencing technologies have made genome sequencing faster and more affordable, enabling the widespread use of genomic information in clinical practice. This has led to the development of personalized treatments based on the genetic makeup of individuals. Moreover, bioinformatics, which combines biological data with statistical analysis and computational tools, plays a crucial role in interpreting the vast amounts of data generated by genomic sequencing. These technological advancements have paved the way for the identification of genetic mutations responsible for various diseases and the development of targeted therapies that improve treatment outcomes, boosting precision medicine market share.

Increasing prevalence of chronic diseases:

The global increase in chronic diseases such as cancer, diabetes, and cardiovascular diseases (CVDs) is one of the crucial precision medicine market trends aiding in market expansion. These conditions are leading causes of death and disability worldwide, placing a significant burden on healthcare systems. Precision medicine offers a promising approach to managing these diseases, with targeted therapies designed to treat each patient's disease based on their unique genetic profile. This personalized approach not only improves the effectiveness of treatment but also reduces the risk of adverse drug reactions, thereby enhancing patient outcomes and reducing healthcare costs. As the prevalence of these diseases continues to rise, the demand for precision medicine approaches is expected to grow, driving the precision medicine market growth.

Growing investment in research and development:

Investment in research and development (R&D) in the precision medicine industry is acting as another significant growth-inducing factor. Governments, private entities, and philanthropic organizations are increasingly funding R&D activities in precision medicine to uncover novel therapeutic targets and develop new diagnostic tools and treatments. This investment is crucial for the continuous discovery of biomarkers, the development of companion diagnostics, and the advancement of personalized therapies. Such financial support is fueling innovations in the pipeline and accelerating the translation of scientific discoveries into clinical applications, thereby fostering the growth of the precision medicine share.

Shift Towards Personalized Healthcare:

The growing shift towards personalized healthcare, driven by the increasing demand for tailored treatment options and the rising emphasis on preventive medicine is bolstering the precision medicine market growth. Patients and healthcare providers are becoming more aware of the benefits of personalized medicine, such as improved treatment efficacy, minimized trial and error in drug selection, and reduced treatment costs in the long run. This shift is supported by the integration of electronic health records (EHRs) with genomic data, which enhances the ability to tailor medical treatment to individual characteristics. As a result, there is a growing demand for precision medicine solutions, which is expected to boost precision medicine market share.

Precision Medicine Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, technology, application, and end user.

Breakup by Product:

  • Consumables
  • Instruments
  • Services

The report has provided a detailed breakup and analysis of the market based on the product. This includes consumables, instruments, and services.

The growing demand for precision medicine consumables, driven by the recurring need for new reagents and assays in personalized treatment protocols to ensure ongoing precision in patient-specific diagnostic and therapeutic processes is influencing the precision medicine industry.

Besides this, the surge in demand for precision medicine instruments owing to their critical role in advanced diagnostics and therapeutic monitoring, facilitating high-precision, real-time data for personalized healthcare decisions is aiding in market expansion.

Concurrently, the increasing reliance on precision medicine services is fueled by the necessity for expert analysis, interpretation of complex genomic data, and the customization of therapy plans, enhancing the efficacy of personalized treatment strategies.

Breakup by Technology:

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Others

Drug discovery holds the largest share in the market

A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others. According to the report, drug discovery accounted for the largest market share.

The demand for precision medicine in drug discovery is mainly propelled by the necessity to develop more effective, safer medications tailored to individual genetic profiles. This approach leverages high-throughput genomic technologies and bioinformatics, enabling researchers to identify novel therapeutic targets and predict drug responses more accurately. It also facilitates the creation of targeted therapies that significantly improve patient outcomes, reduce adverse effects, and expedite the journey from laboratory research to clinical practice, thus creating a favorable outlook for market expansion.

In line with this, the integration of big data analytics in the healthcare sector for deciphering complex datasets, enabling predictive modeling and personalized treatment strategies is positively impacting the precision medicine industry.

Moreover, the rising demand for bioinformatics, essential in precision medicine for analyzing biological data, especially in understanding genetic variations, which facilitates personalized therapeutic strategies and enhances diagnostic accuracy is impelling the market growth.

In confluence with this, gene sequencing technology is fundamental in identifying genetic disorders and tailoring individualized treatments, which is contributing to its expanding demand in the development of precision medicine.

Additionally, the growing use of companion diagnostics for the effective implementation of precision medicine is aiding in market expansion, as they enable the identification of patients likely to benefit from specific treatments, ensuring targeted therapeutic approaches.

Apart from this, emerging technologies like clustered regularly interspaced short palindromic repeats (CRISPR) gene editing and AI-driven predictive models are propelling precision medicine by enabling groundbreaking personalized treatments and advancing our understanding of complex diseases.

Breakup by Application:

  • Oncology
  • Central Nervous System (CNS)
  • Immunology
  • Respiratory Medicine
  • Infections
  • Others

Oncology holds the largest share in the market

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes oncology, central nervous system (CNS), immunology, respiratory medicine, infections, and others. According to the report, oncology accounted for the largest market share.

The demand for precision medicine in oncology is driven by its potential to revolutionize cancer treatment through personalized therapy. By understanding the genetic mutations and molecular characteristics of individual tumors, precision oncology allows for the development of targeted therapies that are more effective and have fewer side effects than traditional treatments. This tailored approach improves patient outcomes, enhances survival rates, and offers hope for those with previously untreatable cancers.

In addition to this, precision medicine also finds extensive applications in CNS disorders due to its potential to tailor treatments for neurological conditions, enhancing efficacy and reducing side effects tailored to individual genetic profiles.

Furthermore, immunology's growing reliance on precision medicine due to its ability to customize immune therapies, thereby improving treatment outcomes for autoimmune diseases by targeting patient-specific immunological pathways is fueling the market growth.

In confluence with this, the push for precision medicine in respiratory medicine for its capacity to personalize therapies for chronic respiratory diseases, optimizing treatment effectiveness and patient management based on individual genetic variations is fostering market expansion.

Moreover, the increasing demand in infections, driven by the precision medicine approach to develop targeted antimicrobial treatments to effectively combat antibiotic-resistant strains and tailored therapy based on the pathogen's genetic makeup is influencing market growth.

Besides this, precision medicine is also gaining traction for its ability to provide customized solutions across various medical fields, enhancing treatment precision, improving clinical outcomes, and offering novel therapeutic options tailored to individual patient profiles.

Breakup by End User:

  • Hospitals and Clinics
  • Diagnostic Centers
  • Pharma and Biotech Companies
  • Healthcare IT Firms
  • Others

Hospitals and clinics hold the largest share in the market

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, diagnostic centers, pharma and biotech companies, healthcare IT firms, and others. According to the report, hospitals and clinics accounted for the largest market share.

The demand for precision medicine in hospitals and clinics is escalating as these settings increasingly recognize its potential to significantly enhance patient care. By integrating individual genetic information, hospitals and clinics can offer more accurate diagnoses, effective treatments, and personalized care plans. This shift not only improves patient outcomes but also optimizes healthcare resources, reduces hospitalization rates, and tailors patient management, aligning with the evolving expectations of personalized healthcare.

Along with this, the growing need for precise, personalized diagnostic information to facilitate targeted treatment plans and improved patient outcomes is boosting the adoption of precision medicine approaches in diagnostic centers.

Moreover, pharma and biotech companies are increasingly investing in precision medicine to develop targeted therapies that offer higher efficacy and reduced risk, tailoring treatments to individual genetic profiles, which is further impelling the market growth.

In line with this, healthcare information technology (IT) firms play a pivotal role in advancing precision medicine, providing the data management and analytics capabilities essential for interpreting complex genomic data and supporting personalized healthcare solutions.

Other sectors, including research institutions and academic centers, are further boosting the demand for precision medicine by pioneering innovative approaches and technologies that enable personalized treatment strategies and advance the field of individualized care.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest precision medicine market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America's robust healthcare infrastructure, substantial investments in healthcare technology, and a strong emphasis on research and innovation are presenting lucrative opportunities for market expansion. The region's advanced regulatory framework supports the rapid adoption of personalized therapies, while the presence of leading biotech and pharmaceutical companies is fueling continuous advancements in precision medicine. Additionally, the presence of a well-informed population with increasing healthcare expectations is further providing an impetus to the market growth.

Besides this, the strong governmental support in Europe, extensive research collaborations, and well-established healthcare systems prioritizing personalized healthcare solutions and innovation in precision medicine are aiding in market expansion.

Concurrently, rapidly growing healthcare infrastructure, increasing investments in biotechnology, and rising awareness of personalized medicine's benefits are fueling the demand in the Asia Pacific region.

Furthermore, In Latin America, growing healthcare expenditure, increasing focus on research and development, and the rising prevalence of chronic diseases are boosting the adoption of precision medicine.

Apart from this, the demand in the Middle East and Africa is propelled by increasing healthcare investments, government initiatives to incorporate advanced healthcare technologies, and the rising demand for effective, personalized therapeutic approaches.

Leading Key Players in the Precision Medicine Industry:

The competitive landscape of the global precision medicine market is intensely dynamic and characterized by rapid technological advancements, strategic collaborations, and a strong focus on innovation. Major players in the field, including biotechnology firms, pharmaceutical giants, and healthcare IT companies, are continually expanding their product portfolios and enhancing their capabilities through research and development (R&D) investments, mergers and acquisitions, and partnerships with academic institutions and research organizations. These companies are competing fiercely to develop and commercialize precision medicine solutions that include advanced genomic analysis, biomarker detection, and personalized therapeutic interventions. The market is also witnessing a growing emphasis on regulatory compliance and the establishment of robust intellectual property rights, which are crucial for sustaining competitive advantage.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • AstraZeneca plc
  • Bayer AG
  • bioMerieux SA
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Illumina Inc.
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

  • In December 2023, AstraZeneca acquired CAR-T Firm Gracell to enhance its existing capabilities and previous investments in cell therapy in hematology and bring a potential best-in-class treatment to patients living with blood cancers.
  • In May 2023, Bayer launched a business unit focused on developing new Precision Health products across its range of everyday health categories.
  • In February 2023, Roche announced the expansion of its partnership with Janssen Biotech Inc. (Janssen), aiming to develop companion diagnostics for targeted treatments, thereby enhancing their joint research and innovation efforts.

Key Questions Answered in This Report:

  • How has the global precision medicine market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global precision medicine market?
  • What is the impact of each driver, restraint, and opportunity on the global precision medicine market?
  • What are the key regional markets?
  • Which countries represent the most attractive precision medicine market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the precision medicine market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the precision medicine market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the precision medicine market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the orthodontic consumables market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global precision medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Precision Medicine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Big Data Analytics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bioinformatics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Gene Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Drug Discovery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Companion Diagnostics
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Central Nervous System (CNS)
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Immunology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Respiratory Medicine
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Infections
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharma and Biotech Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Healthcare IT Firms
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AstraZeneca plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 bioMerieux SA
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Bristol-Myers Squibb Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Eli Lilly and Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Illumina Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Laboratory Corporation of America Holdings
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Merck KGaA
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Novartis AG
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Pfizer Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Qiagen N.V.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Quest Diagnostics Incorporated
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Thermo Fisher Scientific Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Precision Medicine Market: Major Drivers and Challenges
  • Figure 2: Global: Precision Medicine Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Precision Medicine Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Precision Medicine Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Precision Medicine Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Precision Medicine Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Precision Medicine Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Precision Medicine Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Precision Medicine (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Precision Medicine (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Precision Medicine (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Precision Medicine (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Precision Medicine (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Precision Medicine (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Precision Medicine (Big Data Analytics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Precision Medicine (Big Data Analytics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Precision Medicine (Bioinformatics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Precision Medicine (Bioinformatics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Precision Medicine (Gene Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Precision Medicine (Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Precision Medicine (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Precision Medicine (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Precision Medicine (Companion Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Precision Medicine (Companion Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Precision Medicine (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Precision Medicine (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Precision Medicine (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Precision Medicine (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Precision Medicine (Central Nervous System-CNS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Precision Medicine (Central Nervous System-CNS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Precision Medicine (Immunology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Precision Medicine (Immunology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Precision Medicine (Respiratory Medicine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Precision Medicine (Respiratory Medicine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Precision Medicine (Infections) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Precision Medicine (Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Precision Medicine (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Precision Medicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Precision Medicine (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Precision Medicine (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Precision Medicine (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Precision Medicine (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Precision Medicine (Pharma and Biotech Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Precision Medicine (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Precision Medicine (Healthcare IT Firms) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Precision Medicine (Healthcare IT Firms) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Precision Medicine (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Precision Medicine (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: North America: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: North America: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: United States: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: United States: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Canada: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Canada: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Asia-Pacific: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Asia-Pacific: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: China: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: China: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Japan: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Japan: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: India: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: India: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: South Korea: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: South Korea: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Australia: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Australia: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Indonesia: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Indonesia: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Europe: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Europe: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Germany: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Germany: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: France: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: France: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: United Kingdom: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: United Kingdom: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Italy: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Italy: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Spain: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Spain: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Russia: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Russia: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Others: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Others: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Latin America: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Latin America: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Brazil: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Brazil: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Mexico: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Mexico: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Others: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Others: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Middle East and Africa: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Middle East and Africa: Precision Medicine Market: Breakup by Country (in %), 2023
  • Figure 97: Middle East and Africa: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 98: Global: Precision Medicine Industry: SWOT Analysis
  • Figure 99: Global: Precision Medicine Industry: Value Chain Analysis
  • Figure 100: Global: Precision Medicine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Precision Medicine Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Precision Medicine Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Precision Medicine Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Precision Medicine Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Precision Medicine Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Precision Medicine Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Precision Medicine Market: Competitive Structure
  • Table 8: Global: Precision Medicine Market: Key Players